Definition of Pharmacoeconomic. Meaning of Pharmacoeconomic. Synonyms of Pharmacoeconomic

Here you will find one or more explanations in English for the word Pharmacoeconomic. Also in the bottom left of the page several parts of wikipedia pages related to the word Pharmacoeconomic and, of course, Pharmacoeconomic synonyms and on the right images related to the word Pharmacoeconomic.

Definition of Pharmacoeconomic

No result for Pharmacoeconomic. Showing similar results...

Meaning of Pharmacoeconomic from wikipedia

- Pharmacoeconomics refers to the scientific discipline that compares the value of one pharmaceutical drug or drug therapy to another. It is a sub-discipline...
- also known as ISPOR (and formerly as the International Society for Pharmacoeconomics and Outcomes Research) is a global, nonprofit 501(c)(3) public organization...
- Expert Review of Pharmacoeconomics & Outcomes Research is a bimonthly peer-reviewed medical journal covering all aspects of pharmacoeconomics. It was established...
- discovery is related to pharmacoeconomics, which is the sub-discipline of health economics that considers the value of drugs Pharmacoeconomics evaluates the cost...
- August 2021. Plosker GL, Lamb HM (July 1999). "Diclofenac/misoprostol. Pharmacoeconomic implications of therapy". PharmacoEconomics. 16 (1): 85–98. doi:10...
- Law. 22 April 2019. Ko Y, Malone DC, Armstrong EP (December 2006). "Pharmacoeconomic evaluation of antimuscarinic agents for the treatment of overactive...
- applications, clinical efficacy and cost–effectiveness". Expert Review of Pharmacoeconomics & Outcomes Research. 12 (6): 745–764. doi:10.1586/erp.12.67. PMID 23252357...
- The most common and well-known application of this analysis is in pharmacoeconomics, especially health technology ****essment (HTA). In health economics...
- PMID 25427113. S2CID 205116954. Plosker GL (July 2012). "Quetiapine: a pharmacoeconomic review of its use in bipolar disorder". PharmacoEconomics. 30 (7):...
- de Jong-Van den Berg LT, de Jong PE, de Zeeuw D, et al. (2006). "Pharmacoeconomics of angiotensin II antagonists in type 2 diabetic patients with nephropathy:...